Dose-dependent reduction of hazardous alcohol use in a placebo-controlled trial of naltrexone for smoking cessation (Q34982437)

5 August 2017

title

Dose-dependent reduction of hazardous alcohol use in a placebo-controlled trial of naltrexone for smoking cessation (English)

1 reference

5 August 2017

0 references

0 references

0 references

placebo-controlled trial

1 reference

inferred from title

author

Suchitra Krishnan-Sarin

2

object named as

Suchitra Krishnan-Sarin

0 references

Ned Cooney

object named as

Ned L Cooney

5

0 references

Sherry A McKee

3

object named as

Sherry A McKee

1 reference

5 August 2017

Stephanie S O'Malley

1

1 reference

5 August 2017

Robert F Leeman

4

1 reference

5 August 2017

Boris Meandzija

6

1 reference

5 August 2017

Ran Wu

7

1 reference

5 August 2017

Robert W Makuch

8

1 reference

5 August 2017

publication date

17 September 2008

1 reference

The International Journal of Neuropsychopharmacology

5 August 2017

published in

1 reference

5 August 2017

volume

12

1 reference

5 August 2017

issue

5

1 reference

5 August 2017

page(s)

589-597

1 reference

Moderators of naltrexone's effects on drinking, urge, and alcohol effects in non-treatment-seeking heavy drinkers in the natural environment

5 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094855

Effect of transdermal nicotine replacement on alcohol responses and alcohol self-administration

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094855

The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094855

Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094855

Naltrexone alters subjective and psychomotor responses to alcohol in heavy drinking subjects

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094855

Hazardous and harmful alcohol consumption in primary care.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094855

Meta-analysis of randomized control trials addressing brief interventions in heavy alcohol drinkers

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094855

The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094855

Naltrexone in the treatment of alcohol dependence

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094855

Efficacy of extended-release naltrexone in alcohol-dependent patients who are abstinent before treatment.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094855

Family history of alcoholism influences naltrexone-induced reduction in alcohol drinking.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094855

The Asp40 mu-opioid receptor allele does not predict naltrexone treatment efficacy in heavy drinkers

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094855

A controlled trial of naltrexone augmentation of nicotine replacement therapy for smoking cessation.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094855

Differential effects of nicotine on alcohol consumption in men and women.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094855

Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094855

Mu-opioid receptor binding measured by [11C]carfentanil positron emission tomography is related to craving and mood in alcohol dependence

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094855

Naltrexone effects on alcohol consumption in a clinical laboratory paradigm: temporal effects of drinking

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094855

Targeted naltrexone for early problem drinkers

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094855

Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094855

Naltrexone dampens ethanol-induced cardiovascular and hypothalamic- pituitary-adrenal axis activation

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094855

Serum 6-beta-naltrexol levels are related to alcohol responses in heavy drinkers.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094855

Behavioral responses to ethanol in light and moderate social drinkers following naltrexone pretreatment

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094855

Opioid antagonists for alcohol dependence

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3094855

Naltrexone and coping skills therapy for alcohol dependence. A controlled study

26 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18796184

12 December 2020

inferred from PubMed ID database lookup

Effects of naltrexone pretreatment on the subjective and performance effects of ethanol in social drinkers

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18796184

12 December 2020

inferred from PubMed ID database lookup

Disuse exaggerates the detrimental effects of alcohol on cortical bone

1 reference

Crossref

https://api.crossref.org/works/10.1017%2FS146114570800936X

7 January 2021

inferred from DOI database lookup

The CES-D Scale: A Self-Report Depression Scale for Research in the General Population

1 reference

Crossref

https://api.crossref.org/works/10.1017%2FS146114570800936X

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1017/S146114570800936X

1 reference

5 August 2017

1 reference

5 August 2017

1 reference